Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check3 days agoChange DetectedThe site revision tag was updated from v3.6.0 to v3.6.2, reflecting an updated interface version.SummaryDifference0.1%

- Check17 days agoChange DetectedThe study history now shows that the trial is not enrolling participants. A new revision (v3.6.0) was added, replacing the previous revision (v3.5.5).SummaryDifference0.3%

- Check25 days agoChange DetectedThe revision label in the page history updated from v3.5.4 to v3.5.5, signaling a new build of the page history. This change affects only metadata and does not modify the underlying study information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe history shows the page updating its revision from v3.5.3 to v3.5.4, indicating a new version of the page has been published.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.5.3 was added to the study record history, and the previous revision v3.5.2 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry v3.5.2 was added to the history. The v3.5.0 revision was removed.SummaryDifference0.1%

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.